Capricor therapeutics inc

Major-Pharmaceuticals

CAPR


8840 Wilshire Boulevard
Beverly Hills , CA 90211

Executive/
Director

Price

  • Last Close
  • $ 4.71
    $ +0.02 0.43 %
    Aug 29, 2024
  • 52-Week High/Low
  • $7.09 - $2.71
  • YTD
  • -3.7%

  • Trading Volume
  • 4,504
  • Market Cap Full
  • $ 145M
  • Shares Outstanding
  • 30.8M
    Nov 13, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 129.9% -17.3% 27.1% -13.9% 14.6% -5% 36.4% 17.8% 9.3% 38.9%
Q2 -41.4% 55.5% -75.4% -0.7% 509.8% 4% 9.6% 1.2% 13.3% -4.2%
Q3 -19.8% -18% 265.1% -19.2% -6.8% 8% -21.6% 71.9% -28.5% -
Q4 -24.2% -17.9% -54.2% -61.7% -59.5% -34.7% -27.1% -35.7% 64.7% -
J F M A M J J A S O N D
2024 -17.4% 4% 61.7% 0.2% - - - - - - - -
2023 9.3% 7.8% -7.3% -7.8% 16.5% 5.5% -8% 47.3% -47.2% -17.5% 5.3% 64.7%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    15%-18%-13%-41%-74%213%167%-15%32%27%-4%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.23 0.26 0.17 -0.14 -0.8 -0.3 -0.23 -0.32 -0.31
Q2 0.19 0.26 0.16 -0.14 -0.59 -0.23 -0.21 -0.29 -0.29
Q3 0.18 0.29 0.12 -0.14 -0.43 -0.2 -0.17 -0.26 -0.25
Q4 0.21 0.14 0.11 -0.1 -0.29 -0.15 -0.26 -0.31 -
A 0.8 1 0.6 -0.5 -2.1 -0.9 -0.9 -1.2 -0.85

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 33.7 8.9 22.8 24.3 25.3
Jun 29.1 34.7 14.3 22.9 24.3 25.3
Sep 30.7 3.7 19.7 23 24.3 25.8
Dec 31.1 4.2 20.4 24.1 25.2 30.8

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 0.6 - - - 2
Total Asset Turnover 0.1 - - 0.1 0.2
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 30 21 - - -
Equity multiplier 0.4 0.1 - - 0.2